Tech Company Financing Transactions
Mosaic Therapeutics Funding Round
On 4/4/2023, Mosaic Therapeutics raised $28 million in Series A funding from Cambridge Innovation Capital and Syncona.
Transaction Overview
Company Name
Announced On
4/4/2023
Transaction Type
Venture Equity
Amount
$28,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to further advance its pipeline of targeted oncology therapies for biomarker-stratified populations, progressing its lead programs through preclinical development to IND-enabling studies.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
BioData Innovation Centre Wellcome Genome Campus
Cambridge, England, CB10 1DR
UK
Cambridge, England, CB10 1DR
UK
Phone
Undisclosed
Website
Email Address
Overview
Mosaic is uniquely positioned to deliver on the future of targeted oncology therapeutics, leveraging world-leading research capabilities.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Brian Gladsden
Co-Founder
Mathew Garnett
Co-Founder
Adrian Ibrahim
Co-Founder
Emile Voest
Browse more venture capital transactions:
Prev: 4/4/2023: tado venture capital transaction
Next: 4/4/2023: Spendflo venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on tech company VC transactions. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs